Insider: ALTSHULER DAVID EVP, Chief Scientific Officer - VERTEX PHARMACEUTICALS INC / MA
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 23,281 | 0 | 23,281 |
| Value | $8,890,315.47 | $0.00 | $8,890,315.47 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 05/15/2025 | DDS | 52 | Direct | COM | $424.69 | $22,083.88 | 23,281 |
| 03/13/2025 | DDS | 3,231 | Direct | COM | $510.00 | $1,647,810.00 | 23,281 |
| 03/10/2025 | DDS | 3,231 | Direct | COM | $500.00 | $1,615,500.00 | 26,512 |
| 03/03/2025 | DDS | 3,231 | Direct | COM | $490.00 | $1,583,190.00 | 29,743 |
| 02/25/2025 | DDS | 848 | Direct | COM | $480.95 | $407,845.60 | 40,200 |
| 02/20/2025 | DDS | 1,111 | Direct | COM | $480.00 | $533,280.00 | 45,019 |
| 11/15/2024 | DDS | 15 | Direct | COM | $478.56 | $7,178.40 | 25,813 |
| 05/15/2024 | DDS | 54 | Direct | COM | $430.93 | $23,270.22 | 25,813 |
| 02/26/2024 | DDS | 4,239 | Direct | COM | $425.70 | $1,804,542.30 | 25,813 |
| 02/21/2024 | DDS | 3,002 | Direct | COM | $421.77 | $1,266,153.54 | 34,022 |
| 02/20/2024 | DDS | 4,002 | Direct | COM | $420.79 | $1,684,001.58 | 37,024 |
| 02/12/2024 | DDS | 3,145 | Direct | COM | $420.24 | $1,321,654.80 | 47,588 |
| 11/15/2023 | DDS | 19 | Direct | COM | $369.92 | $7,028.48 | 32,038 |
| 08/09/2023 | DDS | 63 | Direct | COM | $345.51 | $21,767.13 | 32,038 |
| 02/27/2023 | DDS | 3,636 | Direct | COM | $287.23 | $1,044,368.28 | 32,640 |
| 02/27/2023 | DDS | 302 | Direct | COM | $289.60 | $87,459.20 | 32,038 |
| 02/27/2023 | DDS | 300 | Direct | COM | $288.74 | $86,622.00 | 32,340 |
| 02/21/2023 | DDS | 36 | Direct | COM | $291.01 | $10,476.36 | 44,212 |
| 02/21/2023 | DDS | 1,223 | Direct | COM | $292.76 | $358,045.48 | 42,989 |
| 02/21/2023 | DDS | 900 | Direct | COM | $294.73 | $265,257.00 | 40,246 |
| 02/21/2023 | DDS | 1,843 | Direct | COM | $294.03 | $541,897.29 | 41,146 |
| 02/14/2023 | DDS | 842 | Direct | COM | $296.85 | $249,947.70 | 52,754 |
| 02/14/2023 | DDS | 800 | Direct | COM | $295.79 | $236,632.00 | 53,596 |
| 02/14/2023 | DDS | 395 | Direct | COM | $297.97 | $117,698.15 | 52,359 |
| 02/14/2023 | DDS | 1,888 | Direct | COM | $300.11 | $566,607.68 | 48,306 |
| 1 2 3 4 5 6 7 8 9 Next Last You are at page 1 of 9 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research